Tsylana’s Post

Global Orthopedic Implants Market Breakdown by Application (Musculoskeletal conditions, Spine Surgery, Others) by Type (Hip implant, Knee implant, Joint implant, Spine Implant, Others) by End User (Hospitals, Ambulatory Surgical Centers) and by Geography (North America, South America, Europe, Asia Pacific, MEA)

#Resection #Guides Market Size and Projections The Resection Guides Market Size was valued at USD 100 Million in 2023 and is expected to reach USD 140.71 Million by 2031, growing at a 5.5% CAGR from 2024 to 2031. The report comprises of various segments as well an analysis of the trends and factors that are playing a substantial role in the market. The market for resection guides is expanding significantly due to a number of variables. The demand for precise and tailored resection guides is being driven by advancements in orthopedic surgical methods, particularly joint replacement surgery. By helping surgeons remove bone tissue precisely during treatments, these guides improve patient outcomes and lower the risk of problems after surgery. Further supporting market growth is the rising incidence of musculoskeletal conditions including rheumatoid arthritis and osteoarthritis. In addition, the growing number of elderly people and the increasing use of minimally invasive surgical procedures are driving the market's global expansion. Key Players Smith+Nephew Stryker Zimmer Biomet Baxter International Inc. Medtronic B. Braun Group

Questions about managing patients on psoriasis biologics who are undergoing surgery??? Check out my short piece featured on Project LEAD addressing this common question! https://lnkd.in/dERu6Czt

The global Titanium Implant market was valued at US$ 1843.4 million in 2023 and is anticipated to reach US$ 2926.5 million by 2030 witnessing a CAGR of 7.2% during the forecast period 20242030. #TitaniumImplants #MedicalTechnology #OrthopedicSurgery #DentalImplants #CardiovascularHealth #SpinalFixation #BoneReplacement #HealthcareInnovation #MedicalDevices #GlobalMarket

Current treatment options for #pterygium, an #OcularDisease, include over-the-counter topical treatments and surgery — both with considerable drawbacks. That’s why there’s an urgent need for more effective, lasting alternatives.      While there are no FDA-approved drugs for pterygium, Cloudbreak is developing the first potential therapy for this condition, which is now in Phase 3 clinical trials. Learn more about our work: https://lnkd.in/e_UnxjTr 

Orthopedic Study Explores Novel Surgical Techniques and Their Market Implications A recent study in orthopedic surgery explores innovative techniques that could transform patient outcomes. The study analyzes surgical advancements and their impact on clinical efficacy and market access. The research highlights minimally invasive procedures that can improve recovery times and reduce complications, potentially revolutionizing the market and lowering healthcare costs. The study also discusses the market implications and the need for streamlined approval processes to ensure new techniques can reach the market. In conclusion, the study provides valuable insights on how innovative surgical techniques can shape orthopedic care and improve patient outcomes globally. For more details please click the link! https://lnkd.in/dEsph-ed #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical

Do You Think We Only Support Pain Management ? KIC Ventures' portfolio may boast the most comprehensive spine technologies, all designed with our LESS exposure spine surgery philosophy in mind. In this case, leading orthopedic spine surgeon, Dr. Costigan, was faced with a complex cervical revision at C7-T1 and was unhappy with his existing options. After speaking with Dr. Kingsley R. Chin MD MBA, CEO Spine Surgeon Professor Author on his experience and outcomes with the ACIFT Solofuse system from Sagitechnology, he decided to use it based on its features. 3 features of ACIFT Solofuse. 1. Simplified instrumentation allows for easy use through a small incision 2. Cages available in multiple footprints and lordosis, up to 18 degrees. 3. Utilizes only two compression screws for immediate stability. This system is used with NanoFUSE Biologics, placed inside and infront the cage. ACIFT Solo-fuse was developed for Orthopedic surgeons and Neurosurgeons since it was FDA approved in 2015. This post is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities.

Are they telling you SIJ surgery is unnecessary ? What would you do for this young female patient ? Positive history of painful ankylosing spondylitis and this MRI ?   Positive SIJ diagnostic injections and provocative physical examination ? Seen by Interventional Pain The answer is sacroiliac joint fixation, but which technique makes the most sense ? if you are pain management, you may think an intra-articular distraction implant, but with this much inflammation, it is doomed to fail if you are an orthopedic or neurosurgeon, you will think traditional direct lateral mini-open transfixation with three titanium implants. if you believe in LESS Exposure Spine Surgery, you will use the Sacrix interventional spine surgery lateral oblique transfixation technique, with two screws filled with NanoFUSE Biologics, to immediately fixate the joint, to relieve pain and allow NanoFUSE Biologics to fuse the joint. SIJ fusion is necessary in the right patient LESS is More. LEAST LESS Exposure Advanced Spine Technologies Unique technologies invented for the LESS movement. See for yourself: www.NANISX.com Join the movement be a member. be an owner. Invest. www.KICVentures.com NANISX KIC Ventures Sacrix #LESS #Spine #Surgery #exposure #lessexposurespinesurgery #technologies #invented #fusion #backpain #implant #sij #sijfusion #sacroiliacjoint

Global Cataract Surgery Devices Market Research Report 2024(Status and Outlook) Download Free Business Sample Report >>> https://lnkd.in/dqp_2d63 The Global Cataract Surgery Devices Market Size was estimated at USD 6599.67 million in 2023 and is projected to reach USD 8447.50 million by 2029, exhibiting a CAGR of 4.20% during the forecast period. Cataract is an eye-related disease in which clouding of the eye lens is observed that leads to loss of vision. Cataract surgery is the removal of clouded natural lens, and involves implantation of intraocular lens. *Market Segmentation (by Type) -Intraocular Lens (IOL) -Ophthalmic Viscoelastic Device (OVD) -Phacoemulsification Equipment *Key Company Abbott Novartis ZEISS Medical Technology Essilor Group Haag-Streit Johnson & Johnson Beijing Nidek Co., Ltd. Topcon Healthcare VALEANT PHARMACEUTICALS INTERNATIONAL INC Ziemer Ophthalmic Systems HumanOptics Holding AG PhysIOL s.a. Calhoun Vision EyeKon Medical, Inc. Allergan VISIONCARE OPHTHALMIC TECHNOLOGIES INC Essilor Group Lenstec, Inc. STAAR Surgical Glaukos Corporation Sonomed Escalon #cataract #surgery #devices #surgerydevices #cataractsurgery #cataractsurgerydevices #marketing

🎥 Watch the PREFERX System in action—efficiency under 60 seconds! Experience firsthand how our breakthrough delivery system revolutionizes the loading and dispensing of biologics in orthopedic surgeries. Quick, precise, and designed for surgeon ease, PREFERX is changing the game in grafting procedures. 👉 Hit play and see why PREFERX is a must-have in modern surgery suites! #PREFERXSystem #QuickEfficiency #SurgicalInnovation #MD3Inc